Inspira Technologies Targets Mechanical Ventilation Market
Company Announcements

Inspira Technologies Targets Mechanical Ventilation Market

Inspira Technologies Oxy BHN (IINN) has released an update.

Inspira Technologies Oxy BHN Ltd. announced aggressive promotion plans for its ART100 device in the U.S. and other markets, following FDA clearance. The company aims to capture a share of the $19 billion mechanical ventilation market with its next-gen INSPIRA ART (Gen 2) technology, designed to oxygenate blood directly, potentially without intubation. Inspira also highlighted its strategic milestones including multi-site deployment of ART100 and advancement of its HYLA blood sensor and VORTX blood delivery system.

For further insights into IINN stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskInspira Technologies Joins Glo-Med for U.S. Expansion
TheFlyInspira Technologies appoints Glo-Med as primary U.S. distributor
TipRanks Auto-Generated NewsdeskInspira Technologies Unveils Innovative Disposable Kit
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App